Thus, the timed expression of LMP1 together with LMP2A in subsets of mouse B cells allows the study of the major clinically relevant features of human EBV infection in vivo, thereby providing a unique animal model that may be useful for therapeutic testing. This evidence concerns the gene PDLIM7 and Epstein-Barr virus infection.